S.Amdt. 3994Senate115th Congress (2017-2019)2nd degree
S.Amdt. 3994
Sponsored by
Sen. Edward J. Markey (D-MA)
Submitted August 22, 2018
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment submitted
August 22, 2018
Text
Submitted
SA 3994. Mr. MARKEY (for himself and Mr. Hatch) submitted an amendment intended to be proposed to amendment SA 3695 proposed by Mr. Shelby to the bill H.R. 6157, making appropriations for the Department of Defense for the fiscal year ending September 30, 2019, and for other purposes; which was ordered to lie on the table; as follows: At the appropriate place, insert the following: SEC. __. OPIOID LABELING REQUIREMENTS. (a) In General.--Section 305(c) of the Controlled Substances Act (21 U.S.C. 825(c)) is amended-- (1) by inserting ``(1)'' before ``The Secretary''; and (2) by adding at the end the following: ``(2) The label of any container or package containing an opioid or opiate listed in schedule II or III shall, when dispensed (other than administered) to or for a patient, contain a clear, concise warning, in a manner specified by the Secretary by regulation, that the opioids or opiates dispensed can cause dependence, addiction, and overdose.''. (b) Regulations.-- (1) Regulations.--The Secretary of Health and Human Services shall prescribe regulations under section 503(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353(b)) to implement the amendment made by subsection (a) and such regulations shall be effective not later than 2 years after the date of enactment of this Act. (2) Interim rules.--The Secretary of Health and Human Services may issue the regulations required under paragraph (1) by interim rule to the extent necessary to comply with the timing requirement in paragraph (1). ______